Fredrik Schjesvold

Fredrik Schjesvold, MD, PhD, is the Founder and Head of Oslo Myeloma Center, in Oslo, Norway. He is also Head of the Norwegian Myeloma Association, President of the Nordic Myeloma Study Group, and a board member of the European Myeloma Network.

He is Principal Investigator for 4 academic studies and national investigator of 55 clinical trials in multiple myeloma, in addition to being Site Investigator in 11 more. He is a co-author of European (ESMO) and global (IMWG) guidelines, as well as lead author of the Norwegian myeloma guidelines. Furthermore, he is peer reviewer of several international journals, and co-editor of the journal Hemato. He is an international expert on myeloma and has given talks in Europe, America and Asia.